Back to Top Skip to main content Skip to sub-navigation

Army general donates COVID-19 Convalescent Plasma at Tripler

Image of Man wearing mask in hospital chair giving blood. Army Maj. Gen. Michael Place sits to donate COVID-19 Convalescent Plasma. This was his third time donating since contracting the COVID-19 disease in March. (Photo by Mackenzie Walsh, Tripler Army Medical Center.)

Recommended Content:

Coronavirus | Convalescent Plasma Collection Program

The COVID-19 Convalescent Plasma (CCP) Collection Program is a Department of Defense effort to obtain 10,000 units CCP with emphasis on blood donations by members of the military community who have recovered from the disease. CCP will be given to critically ill patients, and to support the development of an effective treatment against the disease. Potential donors should visit the Armed Services Blood Program website at: https://www.militaryblood.dod.mil/Donors/COVID-19andBloodDonation.aspx - to find a complete list of available collection centers.

Army Maj. Gen. Michael Place recently sat in chair at the Tripler Army Medical Center in Honolulu, Hawaii squeezing a red droplet-shaped stress ball. The apheresis machine, which separates plasma from blood, beeped like a video game, echoing something Place had said earlier.

“It’s a virus – we can win.”

COVID-19 doesn’t discriminate against who it infects – even general officers are susceptible.

Place, commanding general of the 18th Medical Command and the U.S. Army Pacific surgeon, contracted COVID-19 in March of this year before coming to Hawaii for his current assignment. He serves as an example of the importance of getting tested even with mild symptoms. He never developed a cough, but experienced a few days of fatigue and was febrile overnight. He stresses the importance of seeking medical guidance and self-isolation to protect your loved ones, even though it is difficult after you no longer feel ill.

Known as COVID-19 Convalescent Plasma – CCP – it’s the liquid part of blood collected from patients who have recovered from the virus and now have antibodies that can be used to help others recover.

This was Place’s third donation of CCP, and his first at Tripler Army Medical Center’s Blood Donor Center. An ardent supporter of the Armed Services Blood Program, Place has been contributing blood and blood products for more than 30 years.

When Place got the call asking him to donate CCP after recovery, he was excited to contribute to the fight and plans to continue donating as long as they let him.

“This is Soldiers and Soldiers’ Families taking care of Soldiers,” Place said.

Convalescent plasma is an additional therapeutic option being used under the Food and Drug Administration’s Investigational New Drug protocol while the world searches for a coronavirus vaccine. The FDA hopes the treatment will improve clinical outcomes in COVID-19 patients. The Defense Health Agency is currently leading an effort to collect 10,000 CCP units by Sept. 30. DHA was halfway towards that goal as of July 30.

After undergoing testing for SARS-CoV-2 antibodies, collected units of plasma will be available for the treatment of COVID-positive patients in military treatment facilities, contributing to the readiness of our force and overall research on this virus. Cleared units are then frozen and remain usable for one year.

Similar to blood donation, plasma cannot be universally donated and units are only compatible with certain blood types.

“The more stockpiles we get filled up, the more lives we can potentially save,” explained Army 1st Lt. Joshua Boggess, officer in charge of the Tripler Blood Donor Center.

The donation process takes a bit longer than a standard blood donation of five to ten minutes. Donating plasma takes just under an hour of collection time. After determining eligibility, staff checks vital signs to ensure patients are healthy enough to donate.

“You sit in this comfortable chair for a little while, they take the plasma from you,” Place said, “and give you some cookies and snacks and some departure gifts.”

To learn more about the Military Health System’s Convalescent Plasma Collection Program, visit https://go.usa.gov/xf8h5. Watch 1st Lt. Joshua Boggess discuss the basics of CCP here: https://www.dvidshub.net/video/761845/covid-convalescent-plasma

For more info on donating, visit www.militaryblood.dod.mil.

You also may be interested in...

DHA-Policy Memorandum 21-004: Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

6205.01

Policy

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

20-004

Policy

Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

3020.01, Change 2

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

3020.01, Change 1

Policy

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

  • Identification #: 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

  • Identification #: 20-003
  • Date: 5/13/2020
  • Type: Memorandums
  • Topics: Coronavirus
Showing results 1 - 12 Page 1 of 1
Refine your search
Last Updated: August 11, 2020

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.